Bionano Genomics, Inc. is a provider of genome analysis solutions that can enable researchers and clinicians to reveal answers to challenging questions in biology and medicine. The Company offers optical genome mapping (OGM) solutions for applications across basic, translational and clinical research. It also offers a platform-agnostic software solution, which integrates sequencing and microarray data designed to provide analysis, visualization, interpretation and reporting of copy number variants, single-nucleotide variants, and absence of heterozygosity across the genome in one consolidated view. The Company additionally offers nucleic acid extraction and purification solutions using proprietary isotachophoresis (ITP) technology. The Company markets and sells OGM systems, including the Saphyr system, which delivers OGM data to enable ultra-sensitive and ultra-specific detection of all classes of structural variation (SV).
公司代碼BNGO
公司名稱Bionano Genomics Inc
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)
員工數量98
證券類型Ordinary Share
年結日Aug 01
公司地址9540 Towne Centre Drive
城市SAN DIEGO
上市交易所NASDAQ OMX - NASDAQ BASIC
國家United States of America
郵編92121
電話18588887600
網址https://bionano.com/
公司代碼BNGO
上市日期Aug 01, 2018
CEOHolmlin (R. Erik)